Preeclampsia – Prediction and Monitoring Factors

1Olson-Chen, C. & Seligman, N.S. (2016). Hypertensive Emergencies in Pregnancy. Crit. Care. Clin., 32(1), 29–41.2660044210.1016/j.ccc.2015.08.006Olson-ChenC.SeligmanN.S.2016Hypertensive Emergencies in PregnancyCrit. Care. Clin321294126600442Search in Google Scholar

2Lo, J.O., Mission, J.F. & Caughey, A.B. (2013). Hypertensive disease of pregnancy and maternal mortality. Curr. Opin. Obstet. Gynecol., 25(2), 124–32.10.1097/GCO.0b013e32835e0ef523403779LoJ.O.MissionJ.F.CaugheyA.B.2013Hypertensive disease of pregnancy and maternal mortalityCurr. Opin. Obstet. Gynecol.2521243223403779Open DOISearch in Google Scholar

3American College of Obstetricians and Gynecologists. (2013). Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet. Gynecol., 122(5), 1122–31.American College of Obstetricians and Gynecologists2013Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in PregnancyObstet. Gynecol.1225112231Search in Google Scholar

4Tranquilli, A.L., Dekker, G., Magee, L., Roberts, J., Sibai, B.M., Steyn, W., Zeeman, G.G. & Brown, M.A. (2014). The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy. Hypertens., 4(2), 97–104.2610441710.1016/j.preghy.2014.02.001TranquilliA.L.DekkerG.MageeL.RobertsJ.SibaiB.M.SteynW.ZeemanG.G.BrownM.A.2014The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHPPregnancy. Hypertens429710426104417Search in Google Scholar

5Sawchuck, D.J. & Wittmann, B.K. (2014). Pre-eclampsia renamed and reframed: Intra-abdominal hypertension in pregnancy. Med. Hypotheses., 83(5), 619–32.10.1016/j.mehy.2014.08.00125189485SawchuckD.J.WittmannB.K.2014Pre-eclampsia renamed and reframed: Intra-abdominal hypertension in pregnancyMed. Hypotheses8356193225189485Open DOISearch in Google Scholar

6Cunningham, M.W. Jr & LaMarca, B.D. (2018). The Risk of Cardiovascular Disease, End-Stage Renal Disease, and Stroke in Post-Partum Women and their Fetuses after a Hypertensive Pregnancy. Am. J. Physiol. Regul. Integr. Comp. Physiol., DOI: 10.1152/ajpregu.00218.2017.CunninghamM.W.JrLaMarcaB.D.2018The Risk of Cardiovascular Disease, End-Stage Renal Disease, and Stroke in Post-Partum Women and their Fetuses after a Hypertensive PregnancyAm. J. Physiol. Regul. Integr. Comp. Physiol.10.1152/ajpregu.00218.2017617262729897824Open DOISearch in Google Scholar

7Dildy, G.A. 3rd, Belfort, M.A. & Smulian, J.C. (2007). Preeclampsia recurrence and prevention. Semin. Perinatol., 31(3), 135–41.10.1053/j.semperi.2007.03.00517531895DildyG.A.3rdBelfortM.A.SmulianJ.C.2007Preeclampsia recurrence and preventionSemin. Perinatol3131354117531895Open DOISearch in Google Scholar

8Duckitt, K. & Harrington, D. (2005). Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ., 330(7491), 565.1574385610.1136/bmj.38380.674340.E0DuckittK.HarringtonD.2005Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studiesBMJ330749156555402715743856Search in Google Scholar

9Mayer-Pickel, K., Stern, C., Eberhard, K., Lang, U., Obermayer-Pietsch, B. & Cervar-Zivkovic, M. (2018). Angiogenic factors in pregnancies of women with antiphospholipid syndrome and systemic lupus erythematosus. J. Reprod. Immunol., 127, 19–23.10.1016/j.jri.2018.04.00229689494Mayer-PickelK.SternC.EberhardK.LangU.Obermayer-PietschB.Cervar-ZivkovicM.2018Angiogenic factors in pregnancies of women with antiphospholipid syndrome and systemic lupus erythematosusJ. Reprod. Immunol.127192329689494Open DOISearch in Google Scholar

10Redman, C.W. (2011). Preeclampsia: a multi-stress disorder. Rev. Med. Interne., 32 Suppl 1, S41–4.2153002010.1016/j.revmed.2011.03.331RedmanC.W.2011Preeclampsia: a multi-stress disorderRev. Med. Interne.32Suppl 1S41421530020Search in Google Scholar

11Young, B.C., Levine, R.J. & Karumanchi, S.A. (2010). Pathogenesis of preeclampsia. Annu. Rev. Pathol., 5, 173–92.10.1146/annurev-pathol-121808-10214920078220YoungB.C.LevineR.J.KarumanchiS.A.2010Pathogenesis of preeclampsiaAnnu. Rev. Pathol.51739220078220Open DOISearch in Google Scholar

12Velauthar, L., Plana, M.N., Kalidindi, M., Zamora, J., Thilaganathan, B., Illanes, S.E., Khan, K.S., Aquilina, J. and Thangaratinam S. (2014). First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55,974 women. Ultrasound. Obstet. Gynecol., 43(5), 500–7.10.1002/uog.1327524339044VelautharL.PlanaM.N.KalidindiM.ZamoraJ.ThilaganathanB.IllanesS.E.KhanK.S.AquilinaJ.ThangaratinamS.2014First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55,974 womenUltrasound. Obstet. Gynecol4355007Open DOISearch in Google Scholar

13Khong, S.L., Kane, S.C., Brennecke, S.P. & da Silva Costa, F. (2015). First-trimester uterine artery Doppler analysis in the prediction of later pregnancy complications. Dis. Markers., 2015, 679730.25972623KhongS.L.KaneS.C.BrenneckeS.P.da Silva CostaF.2015First-trimester uterine artery Doppler analysis in the prediction of later pregnancy complicationsDis. Markers.201567973010.1155/2015/679730Search in Google Scholar

14Sánchez-Aranguren, L.C., Espinosa-González, C.T., González-Ortiz, L.M., Sanabria-Barrera, S.M., Riaño-Medina, C.E., Nuñez, A.F., Ahmed, A., Vasquez-Vivar, J. & López, M. (2018). Soluble Fms-Like Tyrosine Kinase-1 Alters Cellular Metabolism and Mitochondrial Bioenergetics in Preeclampsia. Front. Physiol., 9, 83.2956387710.3389/fphys.2018.00083Sánchez-ArangurenL.C.Espinosa-GonzálezC.T.González-OrtizL.M.Sanabria-BarreraS.M.Riaño-MedinaC.E.NuñezA.F.AhmedA.Vasquez-VivarJ.LópezM.2018Soluble Fms-Like Tyrosine Kinase-1 Alters Cellular Metabolism and Mitochondrial Bioenergetics in PreeclampsiaFront. Physiol.983Search in Google Scholar

15Levine, R.J., Lam, C., Qian, C., Yu, K.F., Maynard, S.E., Sachs, B.P., Sibai, B.M., Epstein, F.H., Romero, R., Thadhani, R. & Karumanchi, S.A. (2006). CPEP Study Group. Soluble endoglin and other circulating anti-angiogenic factors in preeclampsia. N. Engl. J. Med., 355(10), 992–1005.10.1056/NEJMoa055352LevineR.J.LamC.QianC.YuK.F.MaynardS.E.SachsB.P.SibaiB.M.EpsteinF.H.RomeroR.ThadhaniR.KarumanchiS.A.2006CPEP Study GroupSoluble endoglin and other circulating anti-angiogenic factors in preeclampsiaN. Engl. J. Med355109921005Open DOISearch in Google Scholar

16Petsas, G., Jeschke, U., Richter, D.U., Minas, V., Hammer, A., Kalantaridou, S., Toth, B., Tsatsanis, C., Friese, K. & Makrigiannakis, A. (2012). Aberrant expression of corticotropin-releasing hormone in pre-eclampsia induces expression of FasL in maternal macrophages and extravillous trophoblast apoptosis. Mol. Hum. Reprod., 18(11), 535–45.10.1093/molehr/gas02722763913PetsasG.JeschkeU.RichterD.U.MinasV.HammerA.KalantaridouS.TothB.TsatsanisC.FrieseK.MakrigiannakisA.2012Aberrant expression of corticotropin-releasing hormone in pre-eclampsia induces expression of FasL in maternal macrophages and extravillous trophoblast apoptosisMol. Hum. Reprod181153545Open DOISearch in Google Scholar

17De Villiers, C.P., Hedley, P.L., Placing, S., Wøjdemann, K.R., Shalmi, A.C., Carlsen, A.L., Rode, L., Sundberg, K., Tabor, A. & Christiansen, M. (2017). Placental protein-13 (PP13) in combination with PAPP-A and free leptin index (fLI) in first trimester maternal serum screening for severe and early preeclampsia. Clin. Chem. Lab. Med., 56(1), 65–74.28704180De VilliersC.P.HedleyP.L.PlacingS.WøjdemannK.R.ShalmiA.C.CarlsenA.L.RodeL.SundbergK.TaborA.ChristiansenM.2017Placental protein-13 (PP13) in combination with PAPP-A and free leptin index (fLI) in first trimester maternal serum screening for severe and early preeclampsiaClin. Chem. Lab. Med561657410.1515/cclm-2017-0356Search in Google Scholar

18Fleischer, A., Schulman, H., Farmakides, G., Bracero, L., Grunfeld, L., Rochelson, B. & Koenigsberg M. (1986). Uterine artery Doppler velocimetry in pregnant women with hypertension. Am J Obstet Gynecol., 154(4), 806–13.10.1016/0002-9378(86)90462-X3515946FleischerA.SchulmanH.FarmakidesG.BraceroL.GrunfeldL.RochelsonB.KoenigsbergM.1986Uterine artery Doppler velocimetry in pregnant women with hypertensionAm J Obstet Gynecol154480613Open DOISearch in Google Scholar

19Sharma, S., Singh, S., Gujral, U., Oberoi, U. & Kaur, R. (2011). Uterine Artery Notching on Color Doppler Ultrasound and Roll over Test in Prediction of Pregnancy Induced Hypertension. J. Obstet. Gynaecol. India., 61(6), 649–51.10.1007/s13224-011-0110-z23204683SharmaS.SinghS.GujralU.OberoiU.KaurR.2011Uterine Artery Notching on Color Doppler Ultrasound and Roll over Test in Prediction of Pregnancy Induced HypertensionJ. Obstet. Gynaecol. India61664951330792723204683Open DOISearch in Google Scholar

20Konje, J.C., Kaufmann, P., Bell, S.C. & Taylor, D.J. (2001). A longitudinal study of quantitative uterine blood flow with the use of color power angiography in appropriate for gestational age pregnancies. Am. J. Obstet. Gynecol., 185(3), 608–13.1156878610.1067/mob.2001.117187KonjeJ.C.KaufmannP.BellS.C.TaylorD.J.2001A longitudinal study of quantitative uterine blood flow with the use of color power angiography in appropriate for gestational age pregnanciesAm. J. Obstet. Gynecol18536081311568786Search in Google Scholar

21Sharma, N., Jayashree, K. & Nadhamuni, K. (2018). Maternal history and uterine artery wave form in the prediction of early-onset and late-onset preeclampsia: A cohort study. Int. J. Reprod. Biomed. (Yazd)., 16(2), 109–14.29675495SharmaN.JayashreeK.NadhamuniK.2018Maternal history and uterine artery wave form in the prediction of early-onset and late-onset preeclampsia: A cohort studyInt. J. Reprod. Biomed. (Yazd)1621091410.29252/ijrm.16.2.109Search in Google Scholar

22Pedroso, M.A., Palmer, K.R., Hodges, R.J., Costa, F.D.S. & Rolnik, D.L. (2018). Uterine Artery Doppler in Screening for Preeclampsia and Fetal Growth Restriction. Rev. Bras. Ginecol. Obstet., 40(5), 287–93.2991354410.1055/s-0038-1660777PedrosoM.A.PalmerK.R.HodgesR.J.CostaF.D.S.RolnikD.L.2018Uterine Artery Doppler in Screening for Preeclampsia and Fetal Growth RestrictionRev. Bras. Ginecol. Obstet40528793Search in Google Scholar

23Tan, M.Y., Syngelaki, A., Poon, L.C., Rolnik, D.L., O’Gorman, N., Delgado, J.L., Akolekar, R., Konstantinidou, L., Tsavdaridou, M., Galeva, S., Ajdacka, U., Molina, F.S., Persico, N., Jani, J.C., Plasencia, W., Greco, E., Papaioannou, G., Wright, A., Wright, D. & Nicolaides, K.H. (2018). Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation. Ultrasound. Obstet. Gynecol., DOI: 10.1002/uog.19112TanM.Y.SyngelakiA.PoonL.C.RolnikD.L.O’GormanN.DelgadoJ.L.AkolekarR.KonstantinidouL.TsavdaridouM.GalevaS.AjdackaU.MolinaF.S.PersicoN.JaniJ.C.PlasenciaW.GrecoE.PapaioannouG.WrightA.WrightD.NicolaidesK.H.2018Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestationUltrasound. Obstet. Gynecol.10.1002/uog.19112Open DOISearch in Google Scholar

24Abdel Razik, M., Mostafa, A., Taha, S. & Salah, A. (2018). Combined Doppler ultrasound and platelet indices for prediction of preeclampsia in high-risk pregnancies. J. Matern. Fetal. Neonatal. Med., DOI: 10.1080/14767058.2018.148195329804487Abdel RazikM.MostafaA.TahaS.SalahA.2018Combined Doppler ultrasound and platelet indices for prediction of preeclampsia in high-risk pregnanciesJ. Matern. Fetal. Neonatal. Med.10.1080/14767058.2018.1481953Open DOISearch in Google Scholar

25González-González, N.L., González Dávila, E., Padrón, E., Armas Gonzalez, M. & Plasencia, W. (2018). Value of Placental Volume and Vascular Flow Indices as Predictors of Early and Late Preeclampsia at First Trimester. Fetal. Diagn. Ther., DOI: 10.1159/00048143329393218González-GonzálezN.L.González DávilaE.PadrónE.Armas GonzalezM.PlasenciaW.2018Value of Placental Volume and Vascular Flow Indices as Predictors of Early and Late Preeclampsia at First TrimesterFetal. Diagn. Ther.10.1159/000481433Open DOISearch in Google Scholar

26Porto, L.B., Brandão, A.H.F., Leite, H.V. & Cabral, A.C.V. (2017). Longitudinal evaluation of uterine perfusion, endothelial function and central blood flow in early onset pre-eclampsia. Pregnancy. Hypertens., 10, 161–64.10.1016/j.preghy.2017.08.00529153671PortoL.B.BrandãoA.H.F.LeiteH.V.CabralA.C.V.2017Longitudinal evaluation of uterine perfusion, endothelial function and central blood flow in early onset pre-eclampsiaPregnancy. Hypertens1016164Open DOISearch in Google Scholar

27Navaratnam, K., Abreu, P., Clarke, H., Jorgensen, A., Alfirevic, A. & Alfirevic, Z. (2017). Evaluation of agreement of placental growth factor (PlGF) tests and the soluble FMS-like tyrosine kinase 1 (sFlt-1)/PlGF ratio, comparison of predictive accuracy for pre-eclampsia, and relation to uterine artery Doppler and response to aspirin. J. Matern. Fetal. Neonatal. Med., DOI: 10.1080/14767058.2017.1373760.28851242NavaratnamK.AbreuP.ClarkeH.JorgensenA.AlfirevicA.AlfirevicZ.2017Evaluation of agreement of placental growth factor (PlGF) tests and the soluble FMS-like tyrosine kinase 1 (sFlt-1)/PlGF ratio, comparison of predictive accuracy for pre-eclampsia, and relation to uterine artery Doppler and response to aspirinJ. Matern. Fetal. Neonatal. Med.10.1080/14767058.2017.1373760Open DOISearch in Google Scholar

28Lee, R.C., Feinbaum, R.L. & Ambros, V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell., 75(5), 843–54.10.1016/0092-8674(93)90529-YLeeR.C.FeinbaumR.L.AmbrosV.1993The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14Cell75584354Open DOISearch in Google Scholar

29Mens, M.M.J. & Ghanbari, M. (2018). Cell Cycle Regulation of Stem Cells by MicroRNAs. Stem. Cell. Rev., 14(3), 309–22.10.1007/s12015-018-9808-yMensM.M.J.GhanbariM.2018Cell Cycle Regulation of Stem Cells by MicroRNAsStem. Cell. Rev14330922596049429541978Open DOISearch in Google Scholar

30Soltanzadeh-Yamchi, M., Shahbazi, M., Aslani, S. & Mohammadnia-Afrouzi, M. (2018). MicroRNA signature of regulatory T cells in health and autoimmunity. Biomed. Pharmacother., 100, 316–23.10.1016/j.biopha.2018.02.03029453041Soltanzadeh-YamchiM.ShahbaziM.AslaniS.Mohammadnia-AfrouziM.2018MicroRNA signature of regulatory T cells in health and autoimmunityBiomed. Pharmacother1003162329453041Open DOISearch in Google Scholar

31Lam, I.K.Y., Chow, J.X., Lau, C.S. & Chan, V.S.F. (2018). MicroRNA-mediated immune regulation in rheumatic diseases. Cancer. Lett., 431, 201–12.10.1016/j.canlet.2018.05.04429859876LamI.K.Y.ChowJ.X.LauC.S.ChanV.S.F.2018MicroRNA-mediated immune regulation in rheumatic diseasesCancer. Lett.4312011229859876Open DOISearch in Google Scholar

32Bhaskaran, M. & Mohan, M. (2014). MicroRNAs: history, biogenesis, and their evolving role in animal development and disease. Vet. Pathol., 51(4), 759–74.2404589010.1177/0300985813502820BhaskaranM.MohanM.2014MicroRNAs: history, biogenesis, and their evolving role in animal development and diseaseVet. Pathol51475974401325124045890Search in Google Scholar

33Lou, W., Liu, J., Gao, Y., Zhong, G., Chen, D., Shen, J., Bao, C., Xu, L., Pan, J., Cheng, J., Ding, B. & Fan, W. (2017). MicroRNAs in cancer metastasis and angiogenesis. Oncotarget., 8(70), 115787–802.29383201LouW.LiuJ.GaoY.ZhongG.ChenD.ShenJ.BaoC.XuL.PanJ.ChengJ.DingB.FanW.2017MicroRNAs in cancer metastasis and angiogenesisOncotarget87011578780210.18632/oncotarget.23115577781329383201Search in Google Scholar

34Data available on miRBase: the microRNA database http://www.mirbase.org/cgi-bin/browse.pl?org=hsa Data retracted on July 10th 2018.Data available on miRBase: the microRNA databasehttp://www.mirbase.org/cgi-bin/browse.pl?org=hsa Data retracted on July 10th 2018Search in Google Scholar

35Pineles, B.L., Romero, R., Montenegro, D., Tarca, A.L., Han, Y.M., Kim, Y.M., Draghici, S., Espinoza, J., Kusanovic, J.P., Mittal, P., Hassan, S.S. & Kim, C.J. (2007). Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with pre-eclampsia. Am. J. Obstet. Gynecol., 196(3), 261.e1–6.10.1016/j.ajog.2007.01.008PinelesB.L.RomeroR.MontenegroD.TarcaA.L.HanY.M.KimY.M.DraghiciS.EspinozaJ.KusanovicJ.P.MittalP.HassanS.S.KimC.J.2007Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with pre-eclampsiaAm. J. Obstet. Gynecol.1963261.e1617346547Open DOISearch in Google Scholar

36Zhang, Y., Diao, Z., Su, L., Sun, H., Li, R., Cui, H. & Hu, Y. (2010). MicroRNA-155 contributes to preeclampsia by down-regulating CYR61. Am. J. Obstet. Gynecol., 202(5), 466.e1–7.10.1016/j.ajog.2010.01.057ZhangY.DiaoZ.SuL.SunH.LiR.CuiH.HuY.2010MicroRNA-155 contributes to preeclampsia by down-regulating CYR61Am. J. Obstet. Gynecol.2025466.e1720452491Open DOISearch in Google Scholar

37Gellhaus, A., Schmidt, M., Dunk, C., Lye, S.J., Kimmig, R. & Winterhager, E. (2006). Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia. Mol. Hum. Reprod., 12(6), 389–99.1667554510.1093/molehr/gal044GellhausA.SchmidtM.DunkC.LyeS.J.KimmigR.WinterhagerE.2006Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsiaMol. Hum. Reprod1263899916675545Search in Google Scholar

38Dai, Y., Diao, Z., Sun, H., Li, R., Qiu, Z. & Hu, Y. (2011). MicroRNA-155 is involved in the remodelling of human-trophoblast-derived HTR-8/SVneo cells induced by lipopolysaccharides. Hum. Reprod., 26(7), 1882–91.10.1093/humrep/der11821515911DaiY.DiaoZ.SunH.LiR.QiuZ.HuY.2011MicroRNA-155 is involved in the remodelling of human-trophoblast-derived HTR-8/SVneo cells induced by lipopolysaccharidesHum. Reprod26718829121515911Open DOISearch in Google Scholar

39Enquobahrie, D.A., Abetew, D.F., Sorensen, T.K., Willoughby, D., Chidambaram, K. & Williams, M.A. (2011). Placental microRNA expression in pregnancies complicated by preeclampsia. Am. J. Obstet. Gynecol., 204(2), 178.e12–21.10.1016/j.ajog.2010.09.004EnquobahrieD.A.AbetewD.F.SorensenT.K.WilloughbyD.ChidambaramK.WilliamsM.A.2011Placental microRNA expression in pregnancies complicated by preeclampsiaAm. J. Obstet. Gynecol.2042178.e1221304098621093846Open DOISearch in Google Scholar

40Muralimanoharan, S., Maloyan, A., Mele, J., Guo, C., Myatt, L.G. & Myatt, L. (2012). MIR-210 modulates mitochondrial respiration in placenta with preeclampsia. Placenta., 33(10), 816–23.2284029710.1016/j.placenta.2012.07.002MuralimanoharanS.MaloyanA.MeleJ.GuoC.MyattL.G.MyattL.2012MIR-210 modulates mitochondrial respiration in placenta with preeclampsiaPlacenta331081623343955122840297Search in Google Scholar

41Gunel, T., Zeybek, Y.G., Akçakaya, P., Kalelioğlu, I., Benian, A., Ermis, H. & Aydınlı, K. (2011). Serum microRNA expression in pregnancies with preeclampsia. Genet. Mol. Res., 10(4), 4034–40.10.4238/2011.November.8.522095477GunelT.ZeybekY.G.AkçakayaP.KalelioğluI.BenianA.ErmisH.AydınlıK.2011Serum microRNA expression in pregnancies with preeclampsiaGenet. Mol. Res10440344022095477Open DOISearch in Google Scholar

42Shen, L., Li, Y., Li, R., Diao, Z., Yany, M., Wu, M., Sun, H., Yan, G. & Hu Y. (2018). Placenta-associated serum exosomal miR-155 derived from patients with preeclampsia inhibits eNOS expression in human umbilical vein endothelial cells. Int. J. Mol. Med., 41(3), 1731–1739.ShenL.LiY.LiR.DiaoZ.YanyM.WuM.SunH.YanG.HuY.2018Placenta-associated serum exosomal miR-155 derived from patients with preeclampsia inhibits eNOS expression in human umbilical vein endothelial cellsInt. J. Mol. Med4131731173910.3892/ijmm.2018.336729328396Search in Google Scholar

43Winger, E.E., Reed, J.L., Ji, X. & Nicolaides, K. (2018). Peripheral blood cell microRNA quantification during the first trimester predicts preeclampsia: Proof of concept. PLoS One., 13(1), e0190654.29293682WingerE.E.ReedJ.L.JiX.NicolaidesK.2018Peripheral blood cell microRNA quantification during the first trimester predicts preeclampsia: Proof of conceptPLoS One131e019065410.1371/journal.pone.0190654574984529293682Search in Google Scholar

44Luque, A., Farwati, A., Crovetto, F., Crispi, F., Figueras, F., Gratacós, E. & Aran, J.M. (2014). Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancy. Sci. Rep., 4, 4882.24811064LuqueA.FarwatiA.CrovettoF.CrispiF.FiguerasF.GratacósE.AranJ.M.2014Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancySci. Rep.4488210.1038/srep04882401393824811064Search in Google Scholar

45Ngene, N.C. & Moodley, J. (2018). Role of angiogenic factors in the pathogenesis and management of preeclampsia. Int. J. Gynaecol. Obstet., 141(1), 5–13.2922293810.1002/ijgo.12424NgeneN.C.MoodleyJ.2018Role of angiogenic factors in the pathogenesis and management of preeclampsiaInt. J. Gynaecol. Obstet141151329222938Search in Google Scholar

46Bates, D.O., Beazley-Long, N., Benest, A.V., Ye, X., Ved, N., Hulse, R.P., Barratt, S., Machado, M.J., Donaldson, L.F., Harper, S.J., Peiris-Pages, M., Tortonese, D.J., Oltean, S. & Foster, R.R. (2018). Physiological Role of Vascular Endothelial Growth Factors as Homeostatic Regulators. Compr. Physiol., 8(3), 955–979.29978898BatesD.O.Beazley-LongN.BenestA.V.YeX.VedN.HulseR.P.BarrattS.MachadoM.J.DonaldsonL.F.HarperS.J.Peiris-PagesM.TortoneseD.J.OlteanS.FosterR.R.2018Physiological Role of Vascular Endothelial Growth Factors as Homeostatic RegulatorsCompr. Physiol8395597910.1002/cphy.c17001529978898Search in Google Scholar

47Powe, C.E., Levine, R.J. & Karumanchi, S.A. (2011). Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation., 123(24),21690502PoweC.E.LevineR.J.KarumanchiS.A.2011Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular diseaseCirculation.1232410.1161/CIRCULATIONAHA.109.853127314878121690502Search in Google Scholar

48Chau, K., Hennessy, A. & Makris, A. (2017). Placental growth factor and pre-eclampsia. J. Hum. Hypertens., 31(12), 782–786.2911529410.1038/jhh.2017.61ChauK.HennessyA.MakrisA.2017Placental growth factor and pre-eclampsiaJ. Hum. Hypertens3112782786568041329115294Search in Google Scholar

49Abou El Hassan, M., Diamandis, E.P., Karumanchi, S.A., Shennan, A.H. & Taylor, R.N. (2015). Preeclampsia: an old disease with new tools for better diagnosis and risk management. Clin. Chem., 61(5), 694–8.10.1373/clinchem.2014.23056525614469Abou El HassanM.DiamandisE.P.KarumanchiS.A.ShennanA.H.TaylorR.N.2015Preeclampsia: an old disease with new tools for better diagnosis and risk managementClin. Chem615694825614469Open DOISearch in Google Scholar

50Weissgerber, T.L., Rajakumar, A., Myerski, A.C., Edmunds, L.R., Powers, R.W., Roberts, J.M., Gandley, R.E. & Hubel, C.A. (2014). Vascular pool of releasable soluble VEGF receptor-1 (sFLT1) in women with previous preeclampsia and uncomplicated pregnancy. J. Clin. Endocrinol. Metab., 99(3), 978–87.10.1210/jc.2013-327724423299WeissgerberT.L.RajakumarA.MyerskiA.C.EdmundsL.R.PowersR.W.RobertsJ.M.GandleyR.E.HubelC.A.2014Vascular pool of releasable soluble VEGF receptor-1 (sFLT1) in women with previous preeclampsia and uncomplicated pregnancyJ. Clin. Endocrinol. Metab99397887394222824423299Open DOISearch in Google Scholar

51Palmer, K.R., Tong, S. & Kaitu’u-Lino, T.J. (2017). Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis. Mol. Hum. Reprod., 23(2), 69–78.27986932PalmerK.R.TongS.Kaitu’u-LinoT.J.2017Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosisMol. Hum. Reprod232697810.1093/molehr/gaw07727986932Search in Google Scholar

52Gregory, A.L., Xu, G., Sotov, V. & Letarte, M. (2014). Review: the enigmatic role of endoglin in the placenta. Placenta., 35 Suppl, S93–9.10.1016/j.placenta.2013.10.02024252708GregoryA.L.XuG.SotovV.LetarteM.2014Review: the enigmatic role of endoglin in the placentaPlacenta35SupplS93924252708Open DOISearch in Google Scholar

53Cheifetz, S., Bellon, T., Cales, C., Vera, S., Bernabeu, C., Massague, J. & Letarte, M. (1992). Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J. Biol. Chem., 267(27), 19027e30.1326540CheifetzS.BellonT.CalesC.VeraS.BernabeuC.MassagueJ.LetarteM.1992Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cellsJ. Biol. Chem.2672719027e3010.1016/S0021-9258(18)41732-2Search in Google Scholar

54Toporsian, M., Gros, R., Kabir, M.G., Vera, S., Govindaraju, K., Eidelman, D.H., Husain, M. & Letarte, M. (2005). A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ. Res., 96(6), 684e92.15718503ToporsianM.GrosR.KabirM.G.VeraS.GovindarajuK.EidelmanD.H.HusainM.LetarteM.2005A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasiaCirc. Res.966684e9210.1161/01.RES.0000159936.38601.22Search in Google Scholar

55Li, C.G., Wilson, P.B., Bernabeu, C., Raab, U., Wang, J.M. & Kumar, S. (1998). Immunodetection and characterization of soluble CD105-TGF-ß complexes. J. Immunol. Methods., 218, 85e93.9819125LiC.G.WilsonP.B.BernabeuC.RaabU.WangJ.M.KumarS.1998Immunodetection and characterization of soluble CD105-TGF-ß complexesJ. Immunol. Methods21885e9310.1016/S0022-1759(98)00118-5Search in Google Scholar

56Jardim, L.L., Rios, D.R., Perucci, L.O., de Sousa, L.P., Gomes, K.B. & Dusse, L.M. (2015). Is the imbalance between pro-angiogenic and anti-angiogenic factors associated with preeclampsia? Clin. Chim. Acta., 447, 34–8.2598278110.1016/j.cca.2015.05.004JardimL.L.RiosD.R.PerucciL.O.de SousaL.P.GomesK.B.DusseL.M.2015Is the imbalance between pro-angiogenic and anti-angiogenic factors associated with preeclampsia?Clin. Chim. Acta.44734825982781Search in Google Scholar

57David, L., Mallet, C., Mazerbourg, S., Feige, J.J. & Bailly, S. (2007). Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood., 109(5), 1953e61.17068149DavidL.MalletC.MazerbourgS.FeigeJ.J.BaillyS.2007Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cellsBlood10951953e6110.1182/blood-2006-07-03412417068149Search in Google Scholar

58Possomato-Vieira, J.S. & Khalil, R.A. (2016). Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia. Adv Pharmacol., 77, 361–431.10.1016/bs.apha.2016.04.00827451103Possomato-VieiraJ.S.KhalilR.A.2016Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and PreeclampsiaAdv Pharmacol77361431496523827451103Open DOISearch in Google Scholar

59Tarasevičienė, V., Grybauskienė, R. & Mačiulevičienė, R. (2016). sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics. Medicina. (Kaunas)., 52(6), 349–353.10.1016/j.medici.2016.11.00827940029TarasevičienėV.GrybauskienėR.MačiulevičienėR.2016sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnosticsMedicina. (Kaunas)52634935327940029Open DOISearch in Google Scholar

60Benovská, M., Opluštilová, A., Pinkavová, J., Hodická, Z. & Cermáková, Z. (2018). The New Possibilities in Early Diagnosis of Preeclampsia by Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor in 16–20 Weeks Gestation. Lab. Med., 49(2), 112–117.10.1093/labmed/lmx07629267975BenovskáM.OpluštilováA.PinkavováJ.HodickáZ.CermákováZ.2018The New Possibilities in Early Diagnosis of Preeclampsia by Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor in 16–20 Weeks GestationLab. Med49211211729267975Open DOISearch in Google Scholar

61Caillon, H., Tardif, C., Dumontet, E., Winer, N. & Masson, D. (2018). Evaluation of sFlt-1/PlGF Ratio for Predicting and Improving Clinical Management of Preeclampsia: Experience in a Specialized Perinatal Care Center. Ann. Lab. Med., 38(2), 95–101.10.3343/alm.2018.38.2.95CaillonH.TardifC.DumontetE.WinerN.MassonD.2018Evaluation of sFlt-1/PlGF Ratio for Predicting and Improving Clinical Management of Preeclampsia: Experience in a Specialized Perinatal Care CenterAnn. Lab. Med38295101573668529214752Open DOISearch in Google Scholar

62AbdelHalim, R.M., Ramadan, D.I., Zeyada, R., Nasr, A.S. & Mandour, I.A. (2016). Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia: Predictors of Adverse Fetal Outcome? A Cohort Study. Mol. Diagn. Ther., 20(2), 135–49.10.1007/s40291-015-0184-x26790664AbdelHalimR.M.RamadanD.I.ZeyadaR.NasrA.S.MandourI.A.2016Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia: Predictors of Adverse Fetal Outcome? A Cohort StudyMol. Diagn. Ther2021354926790664Open DOISearch in Google Scholar

63Allen, R.E., Rogozinska, E., Cleverly, K., Aquilina, J. & Thangaratinam, S. (2014). Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol., 182, 194–201.2530566210.1016/j.ejogrb.2014.09.027AllenR.E.RogozinskaE.CleverlyK.AquilinaJ.ThangaratinamS.2014Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysisEur. J. Obstet. Gynecol. Reprod. Biol.18219420125305662Search in Google Scholar

64Moore Simas, T.A., Crawford, S.L., Bathgate, S., Yan, J., Robidoux, L., Moore, M. & Maynard, S.E. (2014). Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women. J. Matern. Fetal. Neonatal. Med., 27(10), 1038–48.10.3109/14767058.2013.84741524066977Moore SimasT.A.CrawfordS.L.BathgateS.YanJ.RobidouxL.MooreM.MaynardS.E.2014Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk womenJ. Matern. Fetal. Neonatal. Med271010384824066977Open DOISearch in Google Scholar